The global hyperammonemia treatments market is expected to grow at a compound annual growth rate (CAGR) of 4.77% to reach a valuation of US$ 1,318.05 million in 2023 and US$ 2,100 million by 2033, according to a recent report by Future Market Insights. The increased frequency of urea cycle diseases, as well as extensive research and development, …